# Joe Ciaffoni

> Joe Ciaffoni is CEO of Indivior, appointed on May 8, 2025 after joining its board in December 2024. Previously president and CEO of Collegium Pharmaceutical, he built his career in commercial and operating leadership at companies including Biogen, Endo and Shionogi. In 2026 he helped advance Indivior’s proposed merger with Supernus.

- **Role:** Chief Executive Officer at Indivior
- **Organizations:** Indivior, Collegium Pharmaceutical, Endo International, Biogen, Shionogi, Schering-Plough, Sanofi-Synthelabo, Novartis, Rutgers University
- **Education:** B.A. in Communications, Rutgers University, M.B.A., Rutgers University
- **Known for:** Led Collegium as president and CEO from July 2018 to May 2024., During his tenure, Collegium reported rounded net product revenue of $277 million in 2021 and $567 million in 2023., Chaired Collegium’s diversity, equity and inclusion council, as described in its 2022 ESG report.

## Career timeline

- **Before 2017** — Commercial and senior executive positions at Novartis, Sanofi-Synthelabo, Schering-Plough, Shionogi, Biogen and Endo International.
- **2017** — Joined Collegium as executive vice president and chief operating officer, effective May 31.
- **2018** — Became Collegium CEO and a director effective July 1, succeeding Michael Heffernan.
- **2024** — Stepped down as Collegium president and CEO effective May 24; joined Indivior’s board in December.
- **2025** — Became Indivior CEO on May 8.
- **2026** — Participated in proposed Supernus merger; Indivior shareholders approved it October 15, with closing expected November 2.

## Achievements

- Led Collegium as president and CEO from July 2018 to May 2024.
- During his tenure, Collegium reported rounded net product revenue of $277 million in 2021 and $567 million in 2023.
- Chaired Collegium’s diversity, equity and inclusion council, as described in its 2022 ESG report.
- Moved from independent director to CEO at Indivior in May 2025.

## Latest updates

- **2026-10** — Indivior shareholders approved the proposed Supernus merger October 15, with 94% of votes cast in favor; expected closing November 2.
- **2026-08** — Indivior and Supernus announced a proposed merger with Jack Khattar designated CEO of the combined company.
- **2026-02** — Ciaffoni reported completion of Phase I of the Indivior Action Agenda during the full-year 2025 results announcement.

## Links

- Website: https://www.indivior.com/
- LinkedIn: https://www.linkedin.com/in/joe-ciaffoni-27083118

---

Profile page: https://yespress.io/joe-ciaffoni
Published by YesPress — https://yespress.io
Last updated: 2026-10-22